Becton, Dickinson and Company: Arteriovenous Fistula trials

The registry lists 10 Arteriovenous Fistula studies with Becton, Dickinson and Company as lead sponsor. 1 are open to participants now and 2 have results posted.

Phase 3 1No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF SystemRecruitingNCT04634916Not applicable
• The WavelinQ™ Arterio-Venous Endovascular Fistula: A Global, Post-Market InvestigationTerminatedNCT04626427Not applicableResults posted
• Study Comparing Lutonix AV Drug Coated Balloon vs Standard Balloon for Treatment of Dysfunctional AV FistulaeCompletedNCT02440022Phase 3Results posted
• Post Approval Study of the BARD® COVERA™ Arteriovenous (AV) Stent GraftCompletedNCT04261686Not applicable
• Post Approval Study Investigating Lutonix Drug Coated Balloon for Treatment of Dysfunctional Arteriovenous FistulaeActive, not recruitingNCT03506308Not applicable
• Lutonix® Global AV Registry Investigating Lutonix Drug Coated Balloon for Treatment of Native and Synthetic AV FistulaeCompletedNCT02746159
• Paclitaxel Coated PTA Balloons for Treatment of Dysfunctional AV Fistulae and GraftsWithdrawnNCT02183194Not applicable
• A Prospective Clinical Evaluation of the Total Vascular Access (TVA) FLEX-1 Device Protocol FLEX-1-001CompletedNCT02119845Not applicable
• A Prospective Clinical Evaluation of the Total Vascular Access (TVA) FLEX-1 Device Protocol Flex-1-002-IR Intervention Reduction (IR)CompletedNCT02119832Not applicable
• Novel Endovascular Access Trial (NEAT)CompletedNCT02036671Not applicable